SARS-CoV-2 is a new beta coronavirus, similar to SARS-CoV-1, that emerged at the end of
2019 in the Hubei province of China. It is responsible for coronavirus disease 2019 (COVID …

Abstract Coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2), continues to spread globally despite the worldwide …

The rapid and global spread of a new human coronavirus, Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS-CoV-2) has produced an immediate urgency to discover …

The spike protein of SARS-CoV-2 is known to enable viral invasion into human cells through
direct binding to host receptors including ACE2. An alternate entry receptor for the virus was …

Background and aim The discovery of drugs capable of inhibiting SARS-CoV-2 is a priority
for human beings due to the severity of the global health pandemic caused by COVID-19. To …

Background Angiotensin-converting enzyme 2 (ACE2) is known as the major viral entry site
for SARS-CoV-2. However, viral tissue tropism and high rate of infectivity do not directly …

The global prevalence of COVID-19 disease and the overwhelming increase in death toll
urge scientists to discover new effective drugs. Although the drug discovery process is a …

Today the coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2), has become a global health problem. After more …

Patients with severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) infection
manifest mainly respiratory symptoms. However, clinical observations frequently identified …

Simple Summary Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is
responsible for the pandemic coronavirus disease-2019 (COVID-19), which can lead to …